Vivace Therapeutics Revenue and Competitors

Location

$70M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vivace Therapeutics's estimated annual revenue is currently $852.5k per year.(i)
  • Vivace Therapeutics's estimated revenue per employee is $77,500
  • Vivace Therapeutics's total funding is $70M.

Employee Data

  • Vivace Therapeutics has 11 Employees.(i)
  • Vivace Therapeutics grew their employee count by 10% last year.

Vivace Therapeutics's People

NameTitleEmail/Phone
1
CEO/PresidentReveal Email/Phone
2
VP BiologyReveal Email/Phone
3
Head ChemistryReveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Director, Clinical OperationsReveal Email/Phone
6
Board DirectorsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.3M2131%N/AN/A
Add Company

What Is Vivace Therapeutics?

Vivace Therapeutics is a venture-backed, oncology-focused portfolio-based drug discovery and development company, based in San Mateo, California. Its programs include both small molecule programs targeting the YAP pathway, and bi-specific programs. For more information on the company, please visit the company website www.vivacetherapeutics.com. The company's scientific founders are Dr. Kun-liang Guan of UCSD, Dr. Bin Liu of UCSF and Dr. Sheng Ding of UCSF.

keywords:N/A

$70M

Total Funding

11

Number of Employees

$852.5k

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vivace Therapeutics News

2022-04-06 - Vivace Therapeutics Presents New Preclinical Data Highlighting ...

Combination Treatment Demonstrates Enhanced Efficacy and Delayed Tumor Growth as Compared to Osimertinib Alone in EGFR Mutant Non-Small Cell...

2022-03-30 - Vivace Therapeutics to Present New Data from Preclinical ...

Vivace Therapeutics is a small molecule drug discovery and development company focused on targeting the Hippo pathway. The company is pursuing a...

2022-02-22 - Vivace Therapeutics Announces Issuance of New US Composition ...

About Vivace Therapeutics, Inc. Vivace Therapeutics is a small molecule drug discovery and development company focused on targeting the Hippo...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M11-8%$33.7M
#2
$0.4M11-8%$30.3M
#3
$1.3M11-15%N/A
#4
$1.3M1110%N/A
#5
$1M110%N/A